Source: The Korea Bizwire

Conagen: Conagen Develops High-purity Non-GMO Sulforaphane by Bioconversion

Bedford, Mass., Nov. 29 (Korea Bizwire) - Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion technology, the company plans to begin the commercialization path in 2023. Conagen's bioconversion methods enable the production of sustainable products from many naturally occurring compounds regardless of [...]The post Conagen Develops High-purity Non-GMO Sulforaphane by Bioconversion appeared first on Be Korea-savvy.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Oliver Yu's photo - Co-Founder & CEO of Conagen

Co-Founder & CEO

Oliver Yu

CEO Approval Rating

84/100

Read more